T 0779/24 (Dosing regimen for long-acting Paliperidone esters / JANSSEN) of 12.03.2026
- European Case Law Identifier
- ECLI:EP:BA:2026:T077924.20260312
- Date of decision
- 12 March 2026
- Case number
- T 0779/24
- Online on
- 28 April 2026
- Petition for review of
- -
- Application number
- 16777058.5
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- DOSING REGIMEN FOR MISSED DOSES FOR LONG-ACTING INJECTABLE PALIPERIDONE ESTERS
- Applicant name
- Janssen Pharmaceutica NV
- Opponent name
- Hexal AG
df-mp Dörries Frank-Molnia & Pohlman
STADA Arzneimittel AG - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- RPBA 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 012(4)European Patent Convention Art 83European Patent Convention Art 56
- Keywords
- Late-filed evidence - admitted (yes)
Claim intepretation - description taken into consideration
Sufficiency of disclosure - main request (yes)
Inventive step - main request (yes) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The case is remitted to the opposition division with the order to maintain the patent on the basis of the main request filed on 24 January 2024 and a description to be adapted thereto.